Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 5161 AL 5175

Unmasking BACE1 in aging and age-related diseases

Bao H, Shen Y.

Trends Mol Med. 2023 Feb;29(2):99-111. doi: 10.1016/j.molmed.2022.11.008. Epub 2022 Dec 9.

The Interaction Between NF-κB and Estrogen in Alzheimer's Disease

Mishra P, Davies DA, Albensi BC.

Mol Neurobiol. 2023 Mar;60(3):1515-1526. doi: 10.1007/s12035-022-03152-3. Epub 2022 Dec 13.

Entorhinal cortex dysfunction in Alzheimer's disease

Igarashi KM.

Trends Neurosci. 2023 Feb;46(2):124-136. doi: 10.1016/j.tins.2022.11.006. Epub 2022 Dec 10.

Synaptic degeneration in Alzheimer disease

Tzioras M, McGeachan RI, Durrant CS, Spires-Jones TL.

Nat Rev Neurol. 2023 Jan;19(1):19-38. doi: 10.1038/s41582-022-00749-z. Epub 2022 Dec 13.

Ferroptosis: a potential therapeutic target for Alzheimer's disease

Yang L, Nao J.

Rev Neurosci. 2022 Dec 15;34(5):573-598. doi: 10.1515/revneuro-2022-0121. Print 2023 Jul 26.

From degenerative disease to malignant tumors: Insight to the function of ApoE

Miao G, Zhuo D, Han X, Yao W, Liu C, Liu H, Cao H, Sun Y, Chen Z, Feng T.

Biomed Pharmacother. 2023 Feb;158:114127. doi: 10.1016/j.biopha.2022.114127. Epub 2022 Dec 12.

Modelling Alzheimer's disease using human brain organoids: current progress and challenges

Yanakiev M, Soper O, Berg DA, Kang E.

Expert Rev Mol Med. 2022 Dec 15;25:e3. doi: 10.1017/erm.2022.40.

Fundamental Neurochemistry Review: Incorporating a greater diversity of cell types, including microglia, in brain organoid cultures improves clinical translation

Wenzel TJ, Le J, He J, Alcorn J, Mousseau DD.

J Neurochem. 2023 Mar;164(5):560-582. doi: 10.1111/jnc.15741. Epub 2022 Dec 29.

Action of the Purinergic and Cholinergic Anti-inflammatory Pathways on Oxidative Stress in Patients with Alzheimer's Disease in the Context of the COVID-19 Pandemic

Simões JLB, Sobierai LD, Leal IF, Dos Santos MVR, Coiado JV, Bagatini MD.

Neuroscience. 2023 Feb 21;512:110-132. doi: 10.1016/j.neuroscience.2022.12.007. Epub 2022 Dec 13.

Ghrelin system in Alzheimer's disease

Tian J, Wang T, Du H.

Curr Opin Neurobiol. 2023 Feb;78:102655. doi: 10.1016/j.conb.2022.102655. Epub 2022 Dec 15.

Investigation of the independent role of a rare APOE variant (L28P; APOE*4Pittsburgh) in late-onset Alzheimer disease

Fan K, Francis L, Aslam MM, Bedison MA, Lawrence E, Acharya V, Snitz BE, Ganguli M, DeKosky ST, Lopez OL, Feingold E, Kamboh MI.

Neurobiol Aging. 2023 Feb;122:107-111. doi: 10.1016/j.neurobiolaging.2022.11.007. Epub 2022 Nov 18.

Emerging therapeutics agents and recent advances in drug repurposing for Alzheimer's disease

Neha, Parvez S.

Ageing Res Rev. 2023 Mar;85:101815. doi: 10.1016/j.arr.2022.101815. Epub 2022 Dec 16.

The impact of integrated brain molecular PET measures on DLB cognitive phenotype and clinical course

Perani D.

Brain. 2022 Dec 19;145(12):4157-4159. doi: 10.1093/brain/awac432.

Lecanemab for Alzheimer's disease

Walsh S, Merrick R, Richard E, Nurock S, Brayne C.

BMJ. 2022 Dec 19;379:o3010. doi: 10.1136/bmj.o3010.

Design and application of a customizable relational DataBase to assess clinicopathological correlations and concomitant pathology in neurodegenerative diseases

Journe-Mallet I, Gouju J, Etcharry-Bouyx F, Chauvire V, Guillet-Pichon V, Scherer-Gagou C, Prundean A, Godard S, Lecluse A, Cassereau J, Verny C, Letournel F, Codron P.

Brain Pathol. 2023 May;33(3):e13138. doi: 10.1111/bpa.13138. Epub 2022 Dec 19.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias